Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis.

Wang ZC, Qin YJ, Wang PF, Yang YA, Wen Q, Zhang X, Qiu HY, Duan YT, Wang YT, Sang YL, Zhu HL.

Eur J Med Chem. 2013 Aug;66:1-11. doi: 10.1016/j.ejmech.2013.04.035. Epub 2013 May 9.

PMID:
23777898
2.

Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides.

Wilkinson BL, Bornaghi LF, Houston TA, Innocenti A, Vullo D, Supuran CT, Poulsen SA.

J Med Chem. 2007 Apr 5;50(7):1651-7. Epub 2007 Mar 8.

PMID:
17343373
3.

Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies.

Eldehna WM, Al-Ansary GH, Bua S, Nocentini A, Gratteri P, Altoukhy A, Ghabbour H, Ahmed HY, Supuran CT.

Eur J Med Chem. 2017 Feb 15;127:521-530. doi: 10.1016/j.ejmech.2017.01.017. Epub 2017 Jan 11.

PMID:
28109946
4.

Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.

Garaj V, Puccetti L, Fasolis G, Winum JY, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT.

Bioorg Med Chem Lett. 2004 Nov 1;14(21):5427-33.

PMID:
15454239
5.

Quantum chemical QSAR models to distinguish between inhibitory activities of sulfonamides against human carbonic anhydrases I and II and bovine IV isozymes.

Deeb O, Goodarzi M, Khadikar PV.

Chem Biol Drug Des. 2012 Apr;79(4):514-22. doi: 10.1111/j.1747-0285.2011.01309.x. Epub 2012 Jan 30.

PMID:
22181786
6.
7.

Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.

Carta F, Garaj V, Maresca A, Wagner J, Avvaru BS, Robbins AH, Scozzafava A, McKenna R, Supuran CT.

Bioorg Med Chem. 2011 May 15;19(10):3105-19. doi: 10.1016/j.bmc.2011.04.005. Epub 2011 Apr 6.

PMID:
21515057
9.

Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity.

Suthar SK, Bansal S, Lohan S, Modak V, Chaudhary A, Tiwari A.

Eur J Med Chem. 2013 Aug;66:372-9. doi: 10.1016/j.ejmech.2013.06.003. Epub 2013 Jun 12.

PMID:
23827177
10.

Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity.

Abdel-Hamid MK, Abdel-Hafez AA, El-Koussi NA, Mahfouz NM, Innocenti A, Supuran CT.

Bioorg Med Chem. 2007 Nov 15;15(22):6975-84. Epub 2007 Aug 22.

PMID:
17822907
11.

Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.

Cecchi A, Winum JY, Innocenti A, Vullo D, Montero JL, Scozzafava A, Supuran CT.

Bioorg Med Chem Lett. 2004 Dec 6;14(23):5775-80.

PMID:
15501039
12.

New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform II.

Carta F, Vullo D, Maresca A, Scozzafava A, Supuran CT.

Bioorg Med Chem Lett. 2012 Mar 15;22(6):2182-5. doi: 10.1016/j.bmcl.2012.01.129. Epub 2012 Feb 6.

PMID:
22365761
13.

Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties.

Masereel B, Rolin S, Abbate F, Scozzafava A, Supuran CT.

J Med Chem. 2002 Jan 17;45(2):312-20.

PMID:
11784136
14.

Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives.

Ilies MA, Vullo D, Pastorek J, Scozzafava A, Ilies M, Caproiu MT, Pastorekova S, Supuran CT.

J Med Chem. 2003 May 22;46(11):2187-96.

PMID:
12747790
15.

Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.

Winum JY, Dogné JM, Casini A, de Leval X, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT.

J Med Chem. 2005 Mar 24;48(6):2121-5.

PMID:
15771455
16.

3D-QSAR study of benzene sulfonamide analogs as carbonic anhydrase II inhibitors.

Sethi KK, Verma SM, Prasanthi N, Sahoo SK, Parhi RN, Suresh P.

Bioorg Med Chem Lett. 2010 May 15;20(10):3089-93.

PMID:
20443227
17.

Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with lipophilic sulfonamides.

Franchi M, Vullo D, Gallori E, Pastorek J, Russo A, Scozzafava A, Pastorekova S, Supuran CT.

J Enzyme Inhib Med Chem. 2003 Aug;18(4):333-8.

PMID:
14567548
18.

Carbonic anhydrase inhibitors: design of spin-labeled sulfonamides incorporating TEMPO moieties as probes for cytosolic or transmembrane isozymes.

Cecchi A, Ciani L, Winum JY, Montero JL, Scozzafava A, Ristori S, Supuran CT.

Bioorg Med Chem Lett. 2008 Jun 15;18(12):3475-80. doi: 10.1016/j.bmcl.2008.05.051. Epub 2008 May 17.

PMID:
18513964
19.

New coumarin derivatives as carbonic anhydrase inhibitors.

Karataş MO, Alici B, Cakir U, Cetinkaya E, Demir D, Ergün A, Gençer N, Arslan O.

Artif Cells Nanomed Biotechnol. 2014 Jun;42(3):192-8. doi: 10.3109/21691401.2013.794352. Epub 2013 May 8.

PMID:
23656671
20.

Inhibition of human carbonic anhydrase isozymes I, II and VI with a series of bisphenol, methoxy and bromophenol compounds.

Balaydin HT, Durdaği S, Ekinci D, Sentürk M, Göksu S, Menzek A.

J Enzyme Inhib Med Chem. 2012 Aug;27(4):467-75. doi: 10.3109/14756366.2011.596836. Epub 2011 Aug 4.

PMID:
21815772

Supplemental Content

Support Center